Sign in

CIK 0001658551

  • Non-accelerated filer
  • Smaller reporting company

Amylyx Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464600503
Phone
+1 617-682-0917
Business address
55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,951,125
in 9 filings, $8.0M under 10b5-1 plans

Net −$10,951,125. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-09 Klee Justin B. Co-Chief Executive Officer Sale 10b5-1 −37,483 $29.39 $1.1M 3,575,573
2026-11-09 Klee Justin B. Co-Chief Executive Officer Sale 10b5-1 −62,517 $30.11 $1.9M 3,513,056
2026-09-10 Klee Justin B. Co-Chief Executive Officer Sale −29,025 $32.13 $933K 3,614,495
2026-09-10 Klee Justin B. Co-Chief Executive Officer Sale −1,439 $33.16 $48K 3,613,056
2026-08-18 Klee Justin B. Co-Chief Executive Officer Grant or award +60,039 3,643,520
2026-03-05 Klee Justin B. Co-Chief Executive Officer Grant or award +248,865 3,583,481
2026-03-05 Klee Justin B. Co-Chief Executive Officer Grant or award · Stock Option (Right to Buy) +373,295 373,295
2026-03-02 Klee Justin B. Co-Chief Executive Officer Sale −29,282 $14.47 $424K 3,334,616
2026-02-02 Klee Justin B. Co-Chief Executive Officer Sale −15,500 $14.69 $228K 3,363,898
2026-01-16 Klee Justin B. Co-Chief Executive Officer Option exercise +2,847 $7.57 $22K 3,381,393
2026-01-16 Klee Justin B. Co-Chief Executive Officer Sale −1,995 $13.89 $28K 3,379,398
2026-01-16 Klee Justin B. Co-Chief Executive Officer Option exercise · Stock Option (Right to Buy) −2,847 0
2026-01-15 Klee Justin B. Co-Chief Executive Officer Option exercise +197,153 $7.57 $1.5M 3,514,739
2026-01-15 Klee Justin B. Co-Chief Executive Officer Sale −136,193 $13.58 $1.8M 3,378,546
2026-01-15 Klee Justin B. Co-Chief Executive Officer Option exercise · Stock Option (Right to Buy) −197,153 2,847
2026-01-06 Klee Justin B. Co-Chief Executive Officer Sale −7,715 $11.09 $86K 3,317,586
2025-09-30 Klee Justin B. Co-Chief Executive Officer Sale −29,775 $14.37 $428K 3,325,501
2025-09-30 Klee Justin B. Co-Chief Executive Officer Sale −200 $15.01 $3K 3,325,301
2025-03-31 Klee Justin B. Co-Chief Executive Officer Sale −21,490 $3.46 $74K 3,355,276
2025-03-06 Klee Justin B. Co-Chief Executive Officer Grant or award +180,118 3,376,766

Page 1 of 3 · 47 trades